ArticleDrug design, development and therapy2018

Inactivation of nuclear factor κB by MIP-based drug combinations augments cell death of breast cancer cells.

Menaga Subramaniam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.